Case Type: Mergers & Acquisitions

Sonnet BioTherapeutics, Inc. (NASDAQ: SONN) related to its merger with Rorschach I LLC. Upon completion of the proposed transaction, Sonnet shareholders will own approximately 1% of the combined company.

Skechers U.S.A., Inc. (NYSE: SKX) related to its sale to Beach Acquisitions Co Parent. Upon completion of the proposed transaction, outstanding Skechers stock will be cancelled and converted into the right to receive either (i) $63.00 in cash or (ii) $57.00 in cash plus one limited liability company unit of Beach Acquisitions, depending the Skechers … Read more

Royal Gold, Inc. (NASDAQ: RGLD) related to its merger with Sandstorm Gold Ltd. Upon completion of the proposed transaction, existing Royal Gold shareholders will own approximately 77% of the combined company.

WK Kellogg Co. (NASDAQ: KLG) related to its sale to The Ferrero Group for $23.00 in cash per share without interest to Kellogg shareholders.

DallasNews Corporation (NASDAQ: DALN) related to its sale to Hearst Communications, Inc. for $14.00 in cash per share without interest to DallasNews shareholders.

Blueprint Medicines Corporation (NASDAQ: BPMC) related to its sale to Sanofi, S.A. Under the terms of the proposed transaction, Sanofi will pay $129.00 per share in cash at closing, and Blueprint shareholders also will receive one non-tradeable contingent value right (“CVR”) entitling the holder to receive two potential milestone payments of $2.00 and $4.00 per … Read more

Verona Pharma plc (NASDAQ: VRNA) related to its sale to Merck Sharp & Dohme LLC for $107.00 per American Depository Shares.

CARGO Therapeutics, Inc. (NASDAQ: CRGX) related to its sale to Concentra Biosciences, LLC for $4.379 in cash per CARGO share, plus one non-transferable contingent value right, representing the right to receive: (i) 100% of the closing net cash of CARGO in excess of $217.5 million; and (ii) 80% of the net proceeds from the sale, … Read more

Core Scientific, Inc. (NASDAQ: CORZ) related to its sale to CoreWeave, Inc. Upon completion of the proposed transaction, each outstanding share of Core Scientific common stock will be converted into the right to receive 0.1235 shares of CoreWeave Class A common stock. Core Scientific shareholders will own less than 10% of the combined company.

PB Bankshares Inc. (NASDAQ: PBBK) related to its sale to Norwood Financial Corp. Under the terms of the proposed transaction, PB Bankshares’ shareholders will have the option to elect to receive either 0.7850 shares of Norwood common stock or $19.75 in cash for each common share of PB Bankshares they own. The election is subject … Read more